Cargando…
Platinum drugs in the treatment of non-small-cell lung cancer
The use of chemotherapy is considered standard therapy in patients with locally advanced non-small-cell lung cancer that cannot be treated with radiotherapy and in those with metastatic non-small-cell lung cancer and good performance status. This approach is also accepted in patients with earlier st...
Autores principales: | Cosaert, J, Quoix, E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376170/ https://www.ncbi.nlm.nih.gov/pubmed/12373594 http://dx.doi.org/10.1038/sj.bjc.6600540 |
Ejemplares similares
-
Topotecan in the treatment of relapsed small cell lung cancer
por: Quoix, Elisabeth
Publicado: (2008) -
A Non-Conventional Platinum Drug against a Non-Small Cell Lung Cancer Line
por: Silva, Jéssica D., et al.
Publicado: (2023) -
Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017) -
Non-small-cell lung cancer in a French department, (1982–1997): management and outcome
por: Foeglé, J, et al.
Publicado: (2005) -
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
por: Alfonso-Triguero, Paula, et al.
Publicado: (2023)